| Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs M Agrawal, S Saraf, S Saraf, SG Antimisiaris, MB Chougule, SA Shoyele, ... Journal of controlled release 281, 139-177, 2018 | 494 | 2018 |
| Particle engineering techniques for inhaled biopharmaceuticals SA Shoyele, S Cawthorne Advanced drug delivery reviews 58 (9-10), 1009-1029, 2006 | 386 | 2006 |
| Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery SA Shoyele, A Slowey International journal of pharmaceutics 314 (1), 1-8, 2006 | 188 | 2006 |
| Quercetin regulates β‐catenin signaling and reduces the migration of triple negative breast cancer A Srinivasan, C Thangavel, Y Liu, S Shoyele, RB Den, P Selvakumar, ... Molecular carcinogenesis 55 (5), 743-756, 2016 | 109 | 2016 |
| Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines S Kundur, A Prayag, P Selvakumar, H Nguyen, L McKee, C Cruz, ... Journal of cellular physiology 234 (7), 11103-11118, 2019 | 107 | 2019 |
| Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region M Agrawal, S Saraf, S Saraf, SG Antimisiaris, N Hamano, SD Li, ... Expert opinion on drug delivery 15 (6), 589-617, 2018 | 83 | 2018 |
| The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation SA Shoyele, N Sivadas, SA Cryan Aaps Pharmscitech 12, 304-311, 2011 | 54 | 2011 |
| Therapeutic challenge with a CDK 4/6 inhibitor induces an RB-dependent SMAC-mediated apoptotic response in non–small cell lung cancer C Thangavel, E Boopathi, Y Liu, C McNair, A Haber, M Perepelyuk, ... Clinical Cancer Research 24 (6), 1402-1414, 2018 | 48 | 2018 |
| Codelivery of genistein and miRNA-29b to A549 cells using aptamer-hybrid nanoparticle bioconjugates K Sacko, K Thangavel, SA Shoyele Nanomaterials 9 (7), 1052, 2019 | 45 | 2019 |
| Evaluation of MUC1-aptamer functionalized hybrid nanoparticles for targeted delivery of miRNA-29b to nonsmall cell lung cancer M Perepelyuk, K Sacko, K Thangavel, SA Shoyele Molecular pharmaceutics 15 (3), 985-993, 2018 | 43 | 2018 |
| Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins M Perepelyuk, C Maher, A Lakshmikuttyamma, SA Shoyele International Journal of Nanomedicine, 3533-3544, 2016 | 39 | 2016 |
| Investigation of the stability and cellular uptake of self-associated monoclonal antibody (MAb) nanoparticles by non-small lung cancer cells AR Srinivasan, A Lakshmikuttyamma, SA Shoyele Molecular pharmaceutics 10 (9), 3275-3284, 2013 | 31 | 2013 |
| Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb) C Lawlor, MP O’Sullivan, B Rice, P Dillon, PJ Gallagher, S O’Leary, ... Journal of Materials Science: Materials in Medicine 23, 89-98, 2012 | 29 | 2012 |
| Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation N Dim, M Perepelyuk, O Gomes, C Thangavel, Y Liu, R Den, ... Journal of nanobiotechnology 13, 1-13, 2015 | 28 | 2015 |
| Stable and efficient transfection of siRNA for mutated KRAS silencing using novel hybrid nanoparticles A Lakshmikuttyamma, Y Sun, B Lu, AS Undieh, SA Shoyele Molecular pharmaceutics 11 (12), 4415-4424, 2014 | 25 | 2014 |
| Engineering protein particles for pulmonary drug delivery SA Shoyele Drug Delivery Systems, 149-160, 2008 | 22 | 2008 |
| Controlling the release of proteins/peptides via the pulmonary route SA Shoyele Drug Delivery Systems, 141-148, 2008 | 22 | 2008 |
| Ajazuddin; et al. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region M Agrawal, S Saraf, S Saraf, SG Antimisiaris, N Hamano, SD Li, ... Expert Opin. Drug Deliv 15 (6), 589-617, 2018 | 21 | 2018 |
| siRNA-encapsulated hybrid nanoparticles target mutant K-ras and inhibit metastatic tumor burden in a mouse model of lung cancer M Perepelyuk, O Shoyele, R Birbe, C Thangavel, Y Liu, RB Den, ... Molecular Therapy-Nucleic Acids 6, 259-268, 2017 | 19 | 2017 |
| Influence of surface modification and the pH on the release mechanisms and kinetics of erlotinib from antibody-functionalized chitosan nanoparticles AR Srinivasan, SA Shoyele Industrial & Engineering Chemistry Research 53 (8), 2987-2993, 2014 | 18 | 2014 |
